TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/24/08 19:07 | 11/24/08 | IMA | Inverness Medical Innovations Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Zwanziger Ron | MA | DO | CB,CEO,P | P.d | 992 | 15.50 | 0 | 64 | 1 | 5,409 | I | ||||||||||||||
6/3/08 09:13 | 6/2/08 | IMA | Inverness Medical Innovations Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Zwanziger Ron | MA | DO | CB,CEO,P | P | 998 | 36.16 | 0 | 28 | 1 | 3,345 | I | ||||||||||||||
9/3/04 21:00 | 9/2/04 | IMA | Inverness Medical Innovations Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Zwanziger Ron | MA | DOT | CB,CEO,P | P.m | 158 | 15.78 | 0 | 10 | 0 | 2,826 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |